What is Sydenham’s chorea and what is the prognosis

Sydenham’s chorea is an autoimmune attack on the brain’s movement centers, triggered by a strep infection. The prognosis is good for most, but the “good” hides a real risk of permanent neuropsychiatric damage that the system rarely tracks.

The mechanism is a case of mistaken identity. Group A strep makes proteins that look like proteins on your own heart, joints, and basal ganglia. In some people, the immune system makes antibodies that cross-react. Those antibodies land on the basal ganglia, the part of the brain that smooths and coordinates movement. The result is involuntary jerking, writhing, weakness, and emotional storms. It is not a movement disorder alone. It is an immune attack on the brain, and the brain is not a machine you can reboot.

The trigger is usually a sore throat, sometimes a skin infection, weeks to months earlier. The chorea appears after the infection is gone. That delay is why the link is missed. By the time the jerking starts, the strep test is often negative. The diagnosis is clinical: a history of strep, the typical movements, and no other cause. Antibody tests help but are not definitive. The evidence for the autoimmune mechanism is strong, but the exact antibody that does the damage is still debated. That matters because the treatment is guesswork.

Prognosis is where the honesty gets uncomfortable. Most children recover within months. The jerking fades, and they return to baseline. That is the textbook line. But the textbook line is built on short follow-up and no hard endpoints. The real data shows that up to half of patients have persistent neuropsychiatric problems years later: obsessive-compulsive symptoms, tics, anxiety, poor attention, or subtle motor clumsiness. These are not “mild.” They change a child’s trajectory. The recurrence rate is high, about one in three, especially if strep infections keep coming. Each attack can add damage. The idea that this is a self-limiting childhood illness is a half-truth. It is self-limiting in the sense that the acute jerking stops. It is not self-limiting in the sense that the brain returns to its pre-infection state.

Treatment is weak and unproven. Antibiotics are given to prevent future strep, but they do not reverse the damage already done. Anti-inflammatory drugs like steroids are used, but the trials are small, short, and mostly funded by academic centers with no profit motive. There is no drug approved for the chorea itself. The standard approach is supportive care and time. That is not a treatment. That is a hope.

The evidence base is thin because the disease is rare and the system has no incentive to study it. No big pharma product exists for it. The long-term outcomes are not tracked in any registry. The studies that exist are observational, with small numbers and short follow-up. The confidence in the mechanism is high. The confidence in the prognosis is medium at best. The confidence in treatment is low. If you want the truth: the acute phase resolves in most, but the brain injury is real, and the system does not measure it. The burden of proof for “full recovery” is on the people who claim it, and they have not met it.